Secondary prevention of heart disease with statins

doi:10.1136/bmj.330.7501.1208-a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Findings are unexpected

Robert Fleetcroft (r.fleetcroft@uea.ac.uk), honorary senior lecturer in primary care,
Nicholas Steel, senior lecturer in primary care

University of East Anglia School of Medicine, Health Policy and Practice, Norwich NR4 7TJ
University of East Anglia School of Medicine, Health Policy and Practice, Norwich NR4 7TJ

EDITOR—Wei et al reported that statins are as effective in the community as in clinical trials in the secondary prevention of coronary heart disease, but they have not commented on some even more surprising results.1 They reported benefit for calcium blockers, in contradiction of previous …